Abstracts tagged "patient and health literacy"

Abstract Number: 280 • 2018 ACR/ARHP Annual Meeting
Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus
R. Paola Daly¹, Nicole Wanty², Maggie Maloney¹, Stacey Boyd³, Karin Tse¹ and Karen Goldstein⁴, ¹Lupus Foundation of America, Washington, DC, ²KDH Research & Communication, Atlanta, GA, ³American College of Rheumatology, Atlanta, GA, ⁴Ogilvy, Washington, DC
Background/Purpose: Lupus is a complex, chronic autoimmune disease that has significantly higher prevalence and incidence among minority women.[i] In an effort to reduce the time…
Abstract Number: 970 • 2013 ACR/ARHP Annual Meeting
Incorporating The Health Literacy Universal Precautions Toolkit Quick Start In Academic Rheumatology Practices: Carolina Fellows Collaborative
Adam Dore¹, John Dye², Lara Hourani³, Betsy Hackney⁴, Lisa G. Criscione-Schreiber⁵, Faye N. Hant⁶, Kenneth S. O'Rourke⁷, Beth L. Jonas⁸ and Leigh F. Callahan⁹, ¹Rheumatology, Allergy and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Dept of Med/Rheum Div., Duke University School of Medicine, Durham, NC, ³Pediatrics, Medical University of South Carolina, Charleston, SC, ⁴Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁵Dept of Med/Rheum Div, Duke University School of Medicine, Durham, NC, ⁶Dept of Medicine, Medical Univ of South Carolina, Charleston, SC, ⁷Section on Rheum & Immunology, Wake Forest School of Medicine, Winston-Salem, NC, ⁸Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, ⁹Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC
Background/Purpose: Gaps in health literacy (HL) are associated with increased medication errors, higher health care costs, and inadequate care of chronic medical conditions. Previous studies…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].